CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy
Author
Bassem Mekhaeil
Evelyn Tsakiridis
+10Â more
Gabe Menjolian
Gregory Steinberg
Lindsay Broadfield
Olga-Demetra Biziotis
Panagiotis Zacharidis
Paola Muti
Stanley Liu
Tammy Mathurin
Theodoros Tsakiridis
Thomas Farrell
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy
Author
Bassam Abdulkarim
Bassem Mekhaeil
+10Â more
Evangelia - Evelyn Tsakiridis
Gabe Menjolian
Gregory Steinberg
Lindsay Broadfield
Olga-Demetra Biziotis
Panagiotis Zacharidis
Paola Muti
Tammy Mathurin
Theodoros Tsakiridis
Thomas Farrell
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref